Any tariffs on pharma sector would be counterproductive for Americans: Wockhardt Chairman Habib Khorakiwala

Wockhardt Chairman Habib Khorakiwala warns that potential US tariffs on pharmaceutical products would harm Americans. He highlights India's crucial role in supplying 40% of US prescription drugs at reasonable prices. Imposing tariffs would increase healthcare costs for Americans, given the lengthy FDA approval process and higher manufacturing and research expenses in the US.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2hoD1M3
via IFTTT